These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 23472494

  • 1. To what extent is NICE guidance on the management of rheumatoid arthritis in adults being implemented in clinical practice? A regional survey.
    Tugnet N, Pearce F, Tosounidou S, Obrenovic K, Erb N, Packham J, Sandhu R.
    Clin Med (Lond); 2013 Feb; 13(1):42-6. PubMed ID: 23472494
    [Abstract] [Full Text] [Related]

  • 2. Achievement of NICE quality standards for patients with new presentation of inflammatory arthritis: observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.
    Ledingham JM, Snowden N, Rivett A, Galloway J, Ide Z, Firth J, MacPhie E, Kandala N, Dennison EM, Rowe I.
    Rheumatology (Oxford); 2017 Feb; 56(2):223-230. PubMed ID: 27694337
    [Abstract] [Full Text] [Related]

  • 3. The gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheumatoid arthritis: results from the ESPOIR cohort.
    Benhamou M, Rincheval N, Roy C, Foltz V, Rozenberg S, Sibilia J, Schaeverbeke T, Bourgeois P, Ravaud P, Fautrel B.
    J Rheumatol; 2009 May; 36(5):934-42. PubMed ID: 19286850
    [Abstract] [Full Text] [Related]

  • 4. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [Abstract] [Full Text] [Related]

  • 5. Changes in Disease-Modifying Antirheumatic Drug Treatment for Patients With Rheumatoid Arthritis in the US During the COVID-19 Pandemic: A Three-Month Observational Study.
    Michaud K, Pedro S, Wipfler K, Agarwal E, Katz P.
    Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1322-1331. PubMed ID: 33787086
    [Abstract] [Full Text] [Related]

  • 6. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN, Callaghan R, Allen ME, Rowe IF.
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [Abstract] [Full Text] [Related]

  • 7. Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years.
    Aletaha D, Eberl G, Nell VP, Machold KP, Smolen JS.
    Ann Rheum Dis; 2002 Jul; 61(7):630-4. PubMed ID: 12079906
    [Abstract] [Full Text] [Related]

  • 8. Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis.
    Kim G, Barner JC, Rascati K, Richards K.
    J Manag Care Spec Pharm; 2015 May; 21(5):401-7. PubMed ID: 25943001
    [Abstract] [Full Text] [Related]

  • 9. Disease activity-based management of rheumatoid arthritis in Dutch daily clinical practice has improved over the past decade.
    Spijk-de Jonge MJ, Weijers JM, Boerboom LWM, Huis AMP, Atsma F, Van Hulst LTC, van de Laar MAFJ, Hulscher MEJL, van Riel PLCM.
    Clin Rheumatol; 2020 Apr; 39(4):1131-1139. PubMed ID: 31997083
    [Abstract] [Full Text] [Related]

  • 10. Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice.
    Irvine S, Munro R, Porter D.
    Ann Rheum Dis; 1999 Aug; 58(8):510-3. PubMed ID: 10419871
    [Abstract] [Full Text] [Related]

  • 11. Variation in the use of biologics in the management of rheumatoid arthritis across the UK.
    Choy E, Taylor P, McAuliffe S, Roberts K, Sargeant I.
    Curr Med Res Opin; 2012 Oct; 28(10):1733-41. PubMed ID: 22978773
    [Abstract] [Full Text] [Related]

  • 12. Treatment Patterns with Disease-Modifying Antirheumatic Drugs in U.S. Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis.
    Walsh JA, Pei S, Penmetsa GK, Sauer BC, Patil V, Walker JH, Clewell J, Douglas KM, Clegg DO, Cannon GW, Halwani A.
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1218-1228. PubMed ID: 31663467
    [Abstract] [Full Text] [Related]

  • 13. Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease.
    Machold KP, Stamm TA, Eberl GJ, Nell VK, Dunky A, Uffmann M, Smolen JS.
    J Rheumatol; 2002 Nov; 29(11):2278-87. PubMed ID: 12415582
    [Abstract] [Full Text] [Related]

  • 14. Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study.
    Bonafede MM, Fox KM, Johnson BH, Watson C, Gandra SR.
    Clin Ther; 2012 Feb; 34(2):457-67. PubMed ID: 22284901
    [Abstract] [Full Text] [Related]

  • 15. Time to consultation and disease-modifying antirheumatic drug treatment of patients with rheumatoid arthritis--northern Alberta perspective.
    Nanji JA, Choi M, Ferrari R, Lyddell C, Russell AS.
    J Rheumatol; 2012 Apr; 39(4):707-11. PubMed ID: 22337235
    [Abstract] [Full Text] [Related]

  • 16. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide.
    Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS.
    Ann Rheum Dis; 2002 Apr; 61(4):290-7. PubMed ID: 11874828
    [Abstract] [Full Text] [Related]

  • 17. Time to disease-modifying antirheumatic drug treatment in rheumatoid arthritis and its predictors: a national, multicenter, retrospective cohort.
    Tavares R, Pope JE, Tremblay JL, Thorne C, Bykerk VP, Lazovskis J, Blocka KL, Bell MJ, Lacaille D, Hitchon CA, Fitzgerald AA, Fidler WK, Bookman AA, Henderson JM, Mosher DP, Sholter DE, Khraishi M, Haraoui B, Chen H, Li X, Laupacis A, Boire G, Tomlinson G, Bombardier C.
    J Rheumatol; 2012 Nov; 39(11):2088-97. PubMed ID: 22896027
    [Abstract] [Full Text] [Related]

  • 18. Databases of patients with early rheumatoid arthritis in the USA.
    Sokka T, Willoughby J, Yazici Y, Pincus T.
    Clin Exp Rheumatol; 2003 Nov; 21(5 Suppl 31):S146-53. PubMed ID: 14969067
    [Abstract] [Full Text] [Related]

  • 19. Practice variation in the treatment of rheumatoid arthritis among German rheumatologists.
    Zink A, Listing J, Ziemer S, Zeidler H, German Collaborative Arthritis Centres.
    J Rheumatol; 2001 Oct; 28(10):2201-8. PubMed ID: 11669156
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic and therapeutic delay of rheumatoid arthritis and its relationship with health care devices in Catalonia. The AUDIT study.
    Corominas H, Narváez J, Díaz-Torné C, Salvador G, Gomez-Caballero ME, de la Fuente D, Campoy E, Roig-Vilaseca D, Clavaguera T, Morlà R, Torrente-Segarra V, Arasa X, Gomez-Puerta JA, Möller I, Alegre C, Graell E, Ponce A, Lisbona MP, Pérez-Garcia C, Fíguls R, Sirvent E, Poca V, Sanmartí R.
    Reumatol Clin; 2016 Oct; 12(3):146-50. PubMed ID: 26362843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.